Description:
LETROBOL contains Letrozole 2.5 mg, an oral aromatase inhibitor used to lower estrogen levels. It is widely used in managing hormone-dependent breast cancer in postmenopausal women. This medication supports treatment progression, reduces recurrence risk, and may be part of a long-term therapeutic plan under medical supervision.
Specifications: